CD14抗体标记单核细胞,树突状细胞,组织细胞,肝脏窦状小管中的枯否细胞等。CD14与S100,CD68用于组织细胞增多的淋巴结增生性疾病研究。在单核细胞白血病和组织细胞增生淋巴瘤中肿瘤细胞呈CD14阳性。CD14抗体可以标记弥漫性大B细胞淋巴瘤以及脾边缘区淋巴瘤,但不标记其它B细胞淋巴瘤。
CD68免疫组织化学目的:研究喉鳞状细胞癌组织IL-10及单核细胞,肿瘤相关巨噬细胞在肿瘤微环境中的分布情况.方法:采用免疫组织化学方法对IL-10,CD14,CD68在46例喉鳞状细胞癌组织中的表达进行研究,并探讨三者与临床病理参数之间的关系.结果:喉鳞状细胞癌组织中IL-10,CD14,CD68的表达与临床分期,T分期明显相关(均P<0.01...
嗽嵫各肫刷磁靴叼二辨膂三日河北医科大学研究生学位论文独创性声明本论文是在导师指导下进行的研究工作及取得的研究成果,除了文中特别加以标注等内容外, 文中不包含其他人已经发表或撰写的研究成果, 指导教师对此进行了审定。 本论文由本人独立撰写, 文责自负。研究生签名: 良彳 哆导师签章: 勘主、 珊少户年6...
CD14抗体可用于研究单核细胞,树突状细胞,组织细胞,肝脏窦状小管中的枯否细胞等。CD14与S100,CD68用于研究组织细胞增多的淋巴结增生性疾病。在单核细胞白血病和组织细胞增生淋巴瘤中肿瘤细胞呈CD14阳性。CD14抗体可以作为弥漫性大B细胞淋巴瘤以及脾边缘区淋巴瘤的参考依据,其它B细胞淋巴瘤除外。
该CD14 Monoclonal Antibody. CD14, a 55 kDa glycoprotein, is expressed in monocyte macrophage, Langerhans tissue cells, but not in stem cells or early differentiation of bone marrow cells and thymocytes. CD14 is more specific than CD68 in the differentiat
Moreover, endometriosis-associated changes in the macrophage subtypes occurred only in the CD14+low/CD68+low subpopulation. In this subpopulation, we found an increased macrophage type 2 response that was coupled with an increase in peritoneal T-helper 2 and T-regulatory cell populations in women ...
The upregulated genes in the NR group were primarily enriched in human myeloid cells (e.g., CD14, S100A9, LYZ, CD33, CSF3R, FCN1, IL1RN, CD68, CD36, SPI1, FGR, CYBB, HLA-DRA). In contrast, the genes that were enriched in the R group primarily pertained to T cell activation ...
The histiocytes strongly express S-100 protein and other macrophage-associated antigens (CD14, CD68, CD163) (see Figure 14.12C) • Lesional histiocytes frequently have strong and diffuse nuclear Cyclin D1 expression • The histiocytes are negative for CD1a and langerin • Some cases have ...
CD68 expression was largely restricted to a subset of CD14+ dermal APCs, while both CD14+ and CD1a+ dermal APCs expressed CD11b and CD11c. These findings have important implications for understanding cutaneous immune responses in humans and for the optimization of vaccine delivery via the skin...
Patients with early-stage lung adenocarcinoma have a high risk of recurrent or metastatic disease despite undergoing curative intent therapy. We hypothesized that increased CD14+ cells within the tumor microenvironment (TME) could stratify patient outcom